Alumis (ALMS) Accumulated Depreciation & Amortization (2023 - 2025)
Alumis (ALMS) reported Accumulated Depreciation & Amortization of $3.5 million for Q4 2025, up 9.38% year-over-year from $3.2 million in Q4 2024, and up 34.62% on a QoQ basis from $2.6 million in Q3 2025.
Alumis (ALMS) has 3 years of Accumulated Depreciation & Amortization data on file, last reported at $3.5 million in Q4 2025.
- Quarterly Accumulated Depreciation & Amortization rose 9.38% year-over-year to $3.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $3.5 million (up 9.38% YoY) and the FY2025 annual result came in at $3.5 million, up 9.38% from the prior year.
- Accumulated Depreciation & Amortization climbed to $3.5 million in Q4 2025 per ALMS's latest filing, from $2.6 million in the prior quarter.
- Across five years, Accumulated Depreciation & Amortization topped out at $3.5 million in Q4 2025 and bottomed at $200000.0 in Q2 2023.
- The 3-year median for Accumulated Depreciation & Amortization is $800000.0 (2024), against an average of $1.4 million.
- The widest annual swing landed in 2024, when Accumulated Depreciation & Amortization jumped 300.0%; it then changed 0.0% in 2025.
- Tracing ALMS's Accumulated Depreciation & Amortization over 3 years: stood at $1.3 million in 2023, then jumped by 146.15% to $3.2 million in 2024, then advanced by 9.38% to $3.5 million in 2025.
- Per Business Quant, the three latest ALMS Accumulated Depreciation & Amortization figures stand at $3.5 million (Q4 2025), $2.6 million (Q3 2025), and $900000.0 (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Alumis | 1.84 Bn | 1.75 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.50 Mn |
| Dec 31, 2025 | 3.50 Mn |
| Sep 30, 2025 | 2.60 Mn |
| Sep 30, 2025 | 2.60 Mn |
| Jun 30, 2025 | 900,000.00 |
| Jun 30, 2025 | 900,000.00 |
| Mar 31, 2025 | 800,000.00 |
| Mar 31, 2025 | 800,000.00 |
| Dec 31, 2024 | 3.20 Mn |
| Dec 31, 2024 | 3.20 Mn |
| Sep 30, 2024 | 800,000.00 |
| Sep 30, 2024 | 800,000.00 |
| Jun 30, 2024 | 800,000.00 |
| Jun 30, 2024 | 800,000.00 |
| Mar 31, 2024 | 800,000.00 |
| Mar 31, 2024 | 800,000.00 |
| Dec 31, 2023 | 1.30 Mn |
| Dec 31, 2023 | 1.30 Mn |
| Sep 30, 2023 | 300,000.00 |
| Sep 30, 2023 | 300,000.00 |
| Jun 30, 2023 | 200,000.00 |
| Jun 30, 2023 | 200,000.00 |